Johnson & Johnson Innovation, the incubation arm of healthcare giant Johnson & Johnson (NYSE:JNJ), said today that it’s investing in a variety of medical device and pharmaceutical programs, including 3D printing, coatings and contact lenses.
The new”investments and strategic transactions” feature a joint effort with MIT spinout Inkbit Corp., which is developing “a unique multi-material 3-D printing technology” that’s well-suited to complex consumer products with integrated electronics, the company said. J&J said its Johnson & Johnson Services division will help Inkbit optimize and validate its additive manufacturing system.
Get the full story at our sister site, Medical Design & Outsourcing.